Evidence map›Paper›PMID 42706036›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice].

G C Wu, X Miao, W J Zhang, X An, L N Xia, C W Tang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

G C WuDepartment of Hepatology, Chongqing University Three Gorges Hospital, Chongqing 404000, China Chongqing Municipality Clinical Research Center for Endocrine and Metabolic Diseases, Chongqing 404000, China College of Medicine, Chongqing University, Chongqing 400044, China Laboratory of Digestive Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
X MiaoDepartment of Blood Transfusion, Chongqing University Three Gorges Hospital, Chongqing 404000, China.
W J ZhangDepartment of Hepatology, Chongqing University Three Gorges Hospital, Chongqing 404000, China Chongqing Municipality Clinical Research Center for Endocrine and Metabolic Diseases, Chongqing 404000, China.
X AnDepartment of Hepatology, Chongqing University Three Gorges Hospital, Chongqing 404000, China.
L N XiaDepartment of Hepatology, Chongqing University Three Gorges Hospital, Chongqing 404000, China Chongqing Municipality Clinical Research Center for Endocrine and Metabolic Diseases, Chongqing 404000, China.
C W TangLaboratory of Digestive Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

Chongqing Natural Science Foundation cstc2019jcyj-msxmX0774Chongqing Science and Health Joint Medical Research Project 2025ZDXM020National Natural Science Foundation of China 81873571
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fibroblast Growth FactorsGastrointestinal MicrobiomeLiver Diseases, AlcoholicAnimalsDisease Models, AnimalLipopolysaccharidesLiverMaleMiceMice, Inbred C57BLMice, KnockoutRNA, Ribosomal, 16Sfibroblast growth factor 21Fibroblast Growth FactorsLipopolysaccharidesRNA, Ribosomal, 16S

Identifiers

PMID42706036
PMCPMC13529420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.